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ABSTRACT KL4 is a 21-residue functional peptide mimic of lung surfactant protein B, an essential protein for lowering surface
tension in the alveoli. Its ability to modify lipid properties and restore lung compliance was investigated with circular dichroism,
differential scanning calorimetry, and solid-state NMR spectroscopy. KL4 binds ﬂuid lamellar phase PC/PG lipid membranes and
forms an amphipathic helix that alters lipid organization and acyl chain dynamics. The binding and helicity of KL4 is dependent on
the level of monounsaturation in the fatty acid chains. At physiologic temperatures, KL4 is more peripheral and dynamic in ﬂuid
phase POPC/POPG MLVs but is deeply inserted into ﬂuid phase DPPC/POPG vesicles, resulting in immobilization of the
peptide. Substantial increases in the acyl chain order are observed in DPPC/POPG lipid vesicles with increasing levels of
KL4, and POPC/POPG lipid vesicles show small decreases in the acyl chain order parameters on addition of KL4. Additionally,
a clear effect of KL4 on the orientation of the ﬂuid phase PG headgroups is observed, with similar changes in both lipid environ-
ments. Near the phase transition temperature of the DPPC/POPG lipid mixtures, which is just below the physiologic temperature
of lung surfactant, KL4 causes phase separation with the DPPC remaining in a gel phase and the POPG partitioned between gel
and ﬂuid phases. The ability of KL4 to differentially partition into lipid lamellae containing varying levels of monounsaturation and
subsequent changes in curvature strain suggest a mechanism for peptide-mediated lipid organization and trafﬁcking within the
dynamic lung environment.
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Lung surfactant is a lipid-rich substance containing key
proteins that minimizes surface tension in the alveoli and
provides a barrier against disease (1,2). Lung surfactant
undergoes a cycle of lipid adsorption and resorption at the
alveolar air-fluid interface. Lipid polymorphisms that change
the geometry and arrangement of lipid headgroups have been
postulated to be critical for this process not only in the lung,
but also in other membrane-membrane mediated events
(3,4). The lipid constitution in mammalian lung surfactant
is heterogeneous but is dominated by zwitterionic PC (70–
80%) and 10–20% anionic PG and PI (5); ~50% of the PC
lipids and almost all of the anionic lipids in lung surfactant
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0006-3495/09/05/4085/14 $2.00are monounsaturated. Levels of the lipids are relatively
conserved in the lungs of vertebrates (6), with the preponder-
ance of DPPC being particularly striking. The stability of
DPPC-enriched monolayers at air-water interfaces is of
particular relevance in the lung environment. However, the
lipid composition of lung surfactant is not sufficient to
explain its unique properties. Critical to its function are the
lung surfactant proteins, which are present at relatively low
levels (7). In particular, SP-B, which accounts for 0.7–
1.0% of the dry weight of lung surfactant, or <0.2 mol %
relative to the lipids, is required for proper lung function
(8). Disruption of the SP-B gene in mice confers embryonic
lethality (9) and mutations cause respiratory failure (10,11).
Inadequate protein levels are a leading cause of RDS in
premature infants (12).
A multitude of roles for SP-B in surface tension minimiza-
tion, intracellular surfactant trafficking, and respiratory
dynamics in general have been proposed and experimentally
established (13). Current therapies for RDS primarily rely on
administration of lung surfactant isolates from animal sour-
ces to replenish SP-B (14,15). The native form of SP-B is
a highly hydrophobic, 78–81 residue protein that functions
as a homodimer and contains seven disulfide bridges (16–
18). The hydrophobicity and disulfide bridges within SP-B
make purification or heterologous expression of the protein
in large quantities untenable. Structurally, SP-B has been
postulated to be primarily helical based on CD and FTIR
studies of the isolated protein in a phospholipid environment
(19,20). However, more detailed structural studies of SP-B
4086 Antharam et al.have been precluded by its hydrophobicity and consequent
problematic isolation and purification (21–23). Synthetic,
peptide-based lung surfactant replacements designed to
replicate the properties of SP-B have received noticeable
attention (24) as the use of synthetic analogs would remove
the immunologic risks associated with animal-derived
surfactant and allow for greater restorative consistency.
Peptide mimics that rely on the presumption of amphipathic
helicity in SP-B have been pursued both clinically and as
model systems for understanding the structure and dynamics
of the protein and lipids that impart the unique physical prop-
erties of lung surfactant. Understanding how peptide analogs
of SP-B alter lipid properties could lead to the design of
SP-B mimetics with enhanced biophysical properties and
therapeutic lifetimes. For example, oligo N-substituted
glycines (phenylethyl, 2-butyl, or 4-aminobutyl substituents
attached to the nitrogen of glycine), or peptoids, have been
designed to mimic the helicity of SP-B and have shown
potential (25).
KL4, or sinapultide, was designed based on amino acid
residues 59–80 of SP-B and has particularly strong surface
tension reducing properties (26). The primary amino acid
sequence of KL4 is a repeating pattern of four hydrophobic
leucines separated by hydrophilic lysines: KLLLLKLLLLK
LLLLKLLLLK. KL4 has shown promise as a replacement
for therapies that rely on exogenous SP-B (27–31). KL4-
based surfactant therapy relies on a formulation of the
peptide with DPPC, POPG, and a spreading agent, palmitic
acid. Molecular-level information on how synthetic peptides
can modulate surface tension in alveolar compartments is
limited; however, lucinactant, the clinical name for KL4 in
a lipid formulation, has been approved as an agent for treat-
ment of RDS because of its efficacy. In vitro assays as well
as animal studies have shown the ability of KL4 to lower
surface tension in different lipid systems (26,32). In clinical
studies, administration of lucinactant to very premature
infants was noticeably more effective in treating RDS than
other commercially available formulations (33). KL4
improves respiratory status and was found to prevent the
appearance of diffuse, granular radiopacity seen in chest
radiographs typical of RDS and meconium aspiration
syndrome (27,28). A recent antimicrobial function of KL4
was also suggested, in line with recent reports concerning
the antibacterial properties of SP-B (34,35). However, the
biophysical properties of KL4 and their relation to alleviating
RDS remain the focal point of current investigations, partic-
ularly in regard to its structure and organization in lipid
environments.
Artificial lung surfactant formulations simplify the
problem of studying the underlying biophysical aspects of
lung surfactant function against the complicated, heteroge-
neous background that exists in vivo. Of particular interest
is that KL4 retains many of the macroscopic properties of
SP-B even though it bears little resemblance to the biologi-
cally produced protein other than a similarity in charge distri-Biophysical Journal 96(10) 4085–4098bution to the C-terminus. With an understanding of the prop-
erties of KL4, nonnatural peptide analogs of SP-B that
exploit the protein’s helical and amphipathic qualities could
be made to extend or enhance artificial lung surfactant ther-
apies. Thus, understanding how KL4 affects the molecular
and biophysical properties of lipids is of particular relevance
for the treatment of various forms of RDS. The use of calo-
rimetry and CD in combination with ssNMR can provide
unique insight into KL4-induced changes in lipid phase prop-
erties. In this study, static 2H and 31P NMR, MAS 13C NMR,
CD, and DSC were employed to investigate the properties of
mixtures of KL4 with 4:1 DPPC/POPG and 3:1 POPC/POPG
lipid vesicles. The former lipid composition was selected to
mirror the lipid composition of several lung surfactant
studies and lucinactant. The latter composition is similar to
formulations used in numerous studies of amphipathic
membrane-active peptides (36–38) and allows direct
comparison of the physical properties of KL4 with other bio-
logically active peptides. Lipid phases of these compositions
can also be found in localized areas of the alveoli during the
surfactant cycle.
MATERIALS AND METHODS
Synthesis of KL4
KL4 (KLLLLKLLLLKLLLLKLLLLK) was synthesized via automated
solid-phase peptide synthesis on a Wang resin (ABI 430, ICBR, UF). The
peptide was cleaved from the resin with 90% TFA/5% triisopropyl-silane/
5% water and ether precipitated. The crude product was purified by
reverse-phase high-performance liquid chromatography using an acetoni-
trile/water gradient, and purity was verified by mass spectrometry. Dried
peptide was weighed and dissolved in methanol to a stock concentration
of ~1 mM, and aliquots were analyzed by amino acid analysis (Molecular
Structure Facility, University of California, Davis, CA) for a more accurate
determination of concentration.
Preparation of peptide/lipid samples
POPC, DPPC, POPG, POPC-d31, DPPC-d62, and POPG-d31 were purchased
as chloroform solutions (Avanti Polar Lipids, Alabaster, AL) and concentra-
tions were verified by phosphate analysis (39) (Bioassay Systems, Hayward,
CA). The lipids were mixed at a molar ratio of 4:1 DPPC/POPG and 3:1
POPC/POPG in chloroform and aliquoted. For samples containing peptide,
a methanol solution of KL4 was added to lipid solutions with final protein/
lipid (P/L) molar ratios ranging from <1:1000 to >1:50. The samples were
dried under a stream of nitrogen with the sample temperature maintained at
42–50C in a water bath. The resulting films were suspended in cyclo-
hexane, flash-frozen, and lyophilized overnight to remove residual solvent.
CD experiments
For CD experiments, 3 mg of peptide-lipid powder were solubilized in 1 mL
10 mM HEPES buffer, pH 7.4, with 140 mM NaCl to achieve a concentra-
tion of 40 mM KL4 with 4 mM lipids. Samples were placed in a 50
C water
bath to facilitate solubilization accompanied by three to five freeze-thaw
cycles with vortexing to achieve equilibration. Peptide-lipid MLVs were
extruded through 100 nm filters (Avanti Polar Lipids, Alabaster, AL)
15–25 times above the Tm of the lipids to form LUVs just before CD anal-
ysis. CD experiments were performed on an Aviv model 215 (Aviv, Lake-
wood, NJ) at 45C using a 195–260 nm wavelength range, a 1 nm step size,
KL4 Lipid Interactions 4087and averaging of 10–25 scans. A control spectrum of 40 mMKL4 in TFE was
also collected. Background contributions from the buffer and LUVs were
removed by subtracting appropriate controls.
DSC experiments
For DSC experiments, 2 mg of peptide-lipid powder was solubilized in 1 mL
of 5 mM HEPES buffer, pH 7.4, with 140 mM NaCl, 1 mM EDTA, and, in
some cases, 5 mM CaCl2 to achieve a 3 mM lipid concentration. Samples
were placed in a 50C water bath to facilitate solubilization accompanied
by three to five freeze-thaw cycles with vortexing to achieve equilibration.
Peptide-lipid MLVs were extruded through 100 nm filters (Avanti Polar
Lipids, Alabaster, AL) 15–25 times at 45C to form LUVs and degassed
just before DSC. DSC experiments (MicroCal, LLC, Northampton, MA)
were conducted over a range of 10–70C at a scan rate of 1C/min and
run in triplicate.
31P and 2H NMR experiments
For each static ssNMR sample, 20–30 mg of peptide-lipid powder was
placed in a 5 mm diameter NMR tube with 200–300 mL of buffer containing
5 mMHEPES pH 7.4, 140 mMNaCl, and 1 mMEDTA in 2H depleted water
(Cambridge Isotopes, Andover, MA). Samples were made using 4:1 DPPC-
d62/POPG, 4:1 DPPC/POPG-d31, 3:1 POPC-d31/POPG, 3:1 POPC/POPG-
d31, DPPC-d62, POPC-d31, or POPG-d31 lipid preparations. Some NMR
samples contained 5 mM CaCl2; however, we saw no significant difference
in NMR line shapes between samples with or without Ca2þ. NMR samples
were subjected to three to five freeze-thaw cycles with gentle vortexing to
form MLVs before data collection. 31P NMR data were collected on a 600
MHz Avance system (Bruker, Billerica, MA) using a standard 5 mm broad-
band probe. Proton decoupling (25 kHz) was employed during acquisition
to remove dipolar couplings. Spectra were acquired at 34C, 39C, and
44C with 1024–2048 scans and a 5 s recycle delay between scans to
minimize radiofrequency sample heating. 2H NMR data were collected on
a 500 MHz Bruker Avance system using a standard 5 mm broadband probe
and quad echo sequence (90-t-90-t-acq with t ¼ 30 ms) with a B1 field
of 40 kHz. Spectra were acquired at 34C, 39C, and 44C for all samples
with 1024 or 2048 scans and a 0.5 s recycle delay between scans. To monitor
the phase transitions of the DPPC/POPG mixtures, for some samples spectra
were also collected over a range of 30–44C in 2 increments.
DePaking analysis of NMR data was accomplished using previously pub-
lished algorithms that simultaneously dePake and determine macroscopic
ordering for partially aligned lipid spectra using Tikhonov regularization
(40). 31P NMR spectra were referenced to phosphate buffer before dePaking,
and dePaked spectra were quantitated by fitting the resulting two peaks with
Lorentzian line shapes. Assignments of 2H resonances were made based on
published values (41,42).
MAS NMR analysis
For each sample, 40 mg of lipid containing KL4
13C0-enriched at positions
L9 and L10 at a P/L ratio of 1:33 or 1:100 were hydrated in 1 mL of buffer
containing 10 mM HEPES pH 7.4, 140 mM NaCl, and 1 mM EDTA.
Samples were subjected to 3–5 freeze-thaw cycles with gentle vortexing
to form MLVs before pelleting the lipids by centrifugation. The pellets
were packed directly into MAS rotors and NMR data were collected at
temperatures of ~5C, 25C, and 40C. NMR samples contained ~20
mg of the lipid-peptide mixture.
MAS experiments were performed on a 500 MHz DRX system (Bruker,
Billerica, MA) using a doubly tuned 4 mm magic angle spinning probe
(Doty Scientific, Columbia, SC). CPMAS experiments employed a 1H 90
pulse width of 3.2 ms followed by a contact time of 2 ms and 100 kHz 1H
CW decoupling. A 25% ramp was applied on the 1H channel during cross
polarization. Spectra were acquired at a spinning speed of 5 kHz with a total
of 512–2048 scans for each spectrum. The rotor speed was regulated to
3 Hz for all MAS experiments, and each transient was collected witha sweep width of 50 kHz and 20 ms of acquisition (1024 points) with
a recycle delay of 3 s between transients.
For the 1H spin diffusion experiments (43), residual 13C magnetization
was abolished by four 90 pulses before excitation of 1H magnetization.
After a 90 pulse on the 1H channel, a T2 filter was applied for 10 rotor
periods (2 ms) to dephase 1H magnetization in any rigid molecules before
the t1 period for evolution of the
1H magnetization. After the evolution
period, the magnetization was stored along the z axis for 100–200 ms to
allow 1H spin diffusion before the magnetization was flipped back to the
x-y plane with a 90 pulse. The 1H magnetization was then transferred to
neighboring 13C spins by a short (0.5 ms) cross-polarization period followed
by detection of the 13C signal with 100 kHz 1H CW decoupling. The 2D
spectra were collected with 512 transients per t1 point and 96 spectra were
collected over the course of 19.2 ms in t1 (a dwell time of one rotor period)
using States-Haberkorn-Ruben phase-sensitive detection.
RESULTS
Secondary structure of KL4 interacting with
lipid bilayers
CD spectroscopy was utilized to investigate the conforma-
tion of KL4 in the presence of unilamellar lipid vesicles.
The effects of two lipid systems—a 4:1 DPPC/POPG lipid
mixture and a 3:1 POPC/POPG lipid mixture—on peptide
secondary structure were investigated. Fig. 1 shows the
CD spectra obtained for KL4 in these two environments.
Spectra were collected at 45C to ensure that both lipid
systems were in the liquid lamellar phase. As a control, the
CD spectrum of KL4 in 50% TFE is shown for comparison.
The CD spectra have features characteristic of helical
secondary structure, as evidenced by minima at 206–208
and 222 nm. The spectra differ for the two lipid environ-
ments, and the spectrum for KL4 interacting with 4:1
DPPC/POPG shows greater helicity than the spectrum for
KL4 interacting with 3:1 POPC/POPG lipids. Of interest,
the samples containing DPPC/POPG LUVs have similar
ellipticity to the peptide in TFE, with the minimum at
FIGURE 1 CD spectra at 45C of KL4 at a P/L molar ratio of 1:100 in 4:1
DPPC/POPG (solid dark curve), at a P/L molar ratio of 1:100 in 3:1 POPC/
POPG (dashed curve) and in 50% TFE (solid shade curve). The final peptide
concentration was 40 mM in all three samples.Biophysical Journal 96(10) 4085–4098
4088 Antharam et al.206–208 significantly lower than the minimum at 222 nm.
Similar spectra have been observed for peptides that were
constrained to form p-helices in buffer (44). In a first attempt
to understand the origins of the differences seen in the CD
spectra, the data were fit with standard deconvolution soft-
ware (45), resulting in secondary structure estimates of 40–
45% a-helix, 40–45% random coil, and 10–20% b-sheet
for KL4 in POPC/POPG LUVs and >85% a-helix, <15%
random coil, with negligible b-sheet for KL4 in DPPC/
POPG LUVs. However, the quality of the fits was poor,
particularly for the sample containing DPPC/POPG LUVs,
due to the nonstandard shape of the CD spectra relative to
canonical a-helices, which have minima of similar depths
at 222 and 208 nm, and to the lack of data below 200 nm,
where light scattering from the lipids prevents signal
measurement. Given that KL4 does not form a typical amphi-
pathic a-helix when projected on a helical wheel (Fig. 2 A), it
is highly probable that the peptide forms helices that might
vary in helical pitch or even hydrogen-bonding patterns.
More amphipathic helical wheel projections for KL4, which
represent structures that KL4 might adopt in lipid bilyers,
along with their hydrophobic moment values, are shown
for comparison (Fig. 2, B and C).
DSC suggests KL4 decreases DPPC/POPG
lipid miscibility
Shown in Fig. 3 are DSC thermograms for 4:1 DPPC/POPG
LUVs containing varying levels of KL4. Adding POPG to
DPPC in a 1:4 ratio results in a lipid transition temperature
below 37C, >4 lower than the Tm for pure DPPC, due to
the monounsaturated fatty acid group in POPG. Of note is
the gradual shift of Tm to a higher temperature as KL4 levels
are increased. At 0.2 mol % peptide, a higher temperature
shoulder appears in the phase transition. This shoulder grows
with increasing levels of peptide until two peaks with Tm
values of 37C and 39C are clearly seen at 1 mol % peptide.
At 2 and 3 mol % peptide the higher temperature transition
becomes dominant. This bifurcation in the phase transition
suggests domain separation of the lipids, possibly due to
electrostatic interactions between the cationic peptide and
anionic POPG. This phase separation is striking given the
low percentages of peptide, and is similar to behavior noted
A B C
FIGURE 2 Helical wheel representations of KL4 assuming (A) a canonical
a-helix, (B) a helix with a pitch intermediate between a-helix and p-helix,
and (C) a p-helix.Biophysical Journal 96(10) 4085–4098previously for 3:1 DPPC/POPG MLVs (46). It also agrees
with a previous observation of domain formation via Lang-
muir trough studies of KL4 interacting with fluorescently
labeled DPPC in a DPPC/POPG/PA system (47). This
behavior may be important for the function of the peptide
in vivo during the lipid resorption/adsorption cycle (13).
However, from the DSC data it is not possible to determine
whether the separate transitions are due to the formation of
separate POPG-enriched and POPG-depleted DPPC lipid
domains or to another physical phenomenon. In particular,
leucine-rich TM peptides have been demonstrated to cause
phase separation when interacting with DPPC. The two tran-
sitions observed in DSC traces are attributed to melting of
bulk lipids and peptide-associated lipids (48). Given the
high percentage of leucines in KL4, close association of
the peptide with lipid fatty acyl chains is expected. Other
than a small increase at low concentrations of KL4, no signif-
icant change in DHcal was seen. DSC samples with 5 mM
CaCl2 showed a similar behavior, indicating that the effects
of KL4 on the Lb-to-La phase transition in this lipid system is
not calcium-dependent.
Effect of KL4 on lipid headgroup interactions
ssNMR was used to obtain a molecular-level view of how
KL4 interacts with phospholipids in the two bilayer systems.
31P NMR spectra at 44C for 3:1 POPC/POPG and 4:1
DPPC/POPG MLVs containing varying concentrations of
KL4 were collected and dePaked, allowing a clear determina-
tion of the individual, time-averaged CSAs of the PC and
PG headgroups (Fig. 4). Because data were collected on
a 600 MHz NMR spectrometer, macroscopic alignment of
the vesicles occurred, as evidenced by the downfield features
in the lamellar line shapes being lower in intensity than
is typically seen for phospholipid dispersions at lower
FIGURE 3 DSC scans for 4:1 DPPC/POPG LUVs with KL4 at the indi-
cated P/L ratios. The onset of phase separation is apparent at a P/L ratio
of 1:260 and continues with increasing amounts of peptide.
KL4 Lipid Interactions 4089magnetic fields (Supporting Material). As such, standard
fitting of the chemical shift powder patterns was not possible.
Instead, a dePaking algorithm that includes a Tikhonov reg-
ularization procedure for correcting for the macroscopic
alignment was utilized (40). From this analysis it is possible
to determine the spans of the CSA patterns and hence deduce
the effects of KL4 on the phospholipid headgroups. Differ-
ences in PG and PC headgroup orientations relative to the
membrane normal lead to differences in their CSA values
(49). With increasing levels of KL4, the PC CSA was
invariant, but the PG CSA lessened with increasing peptide
levels. The decrease in the POPG CSA on addition of KL4
was consistently seen in all lipid systems studied, regardless
of which lipid was deuterated. To assess the underlying
cause of the changes in POPG CSAs, 31P NMR spectra
were collected on individual lipids alone and with 1.5 mol
% KL4; the
31P NMR spectra and their corresponding de-
Paked spectra are provided in the Supporting Material.
Only small changes in individual lipid CSAs were seen on
addition of KL4. However, the CSA for POPG alone is
significantly smaller than that observed for POPG in 4:1
DPPC/POPG or 3:1 POPC/POPG mixtures before the addi-
tion of KL4. For the binary lipid mixtures containing higher
concentrations of KL4, the
31P CSAs are more comparable to
a
b
FIGURE 4 DePaked phosphorous NMR spectra of (top) 4:1 DPPC/POPG
and (bottom) 3:1 POPC/POPG MLVs with KL4 at the indicated P/L ratios
with fits assuming Lorentzian line shapes.those of the neat lipids. Thus, KL4 clearly affects the interac-
tions of the PC and PG lipids, and possibly their miscibility.
Table 1 shows CSA values for lipid mixtures and compari-
sons with individual lipids. These results indicate that
when POPG interacts with PC headgroups, electrostatic
interactions cause the PG headgroups to reorient, leading
to a subsequent increase in their averaged CSA values. Addi-
tion of KL4 disrupts this interaction, causing the PG CSAs to
move toward values seen for POPG alone.
At low P/L ratios, lipid alignment along the static
magnetic field is seen in spectra of lipid systems, as evi-
denced by disproportionately high perpendicular edges for
the static powder patterns. Lipid alignment in high magnetic
fields was observed previously (40,50,51) and is caused by
the negative diamagnetic susceptibility inherent to phospho-
lipids. In lipid bilayers, the cooperative alignment of the
magnetic moments of individual lipid molecules leads to
a large bulk magnetic susceptibility resulting in an overall
macroscopic ordering of the sample within the magnetic
field. Increasing amounts of KL4 disrupt this alignment in
a concentration-dependent manner, as evidenced by the
gradual increase in the parallel edges of the 31P NMR
spectra. The reduction in alignment of the lipid lamellae on
addition of KL4 suggests that the peptide disrupts lipid-lipid
interactions. The ability of peptides to affect lipid magnetic
field alignment, particularly for amphipathic peptides, was
previously noted (52–56). However, reports on the influence
of amphipathic peptides on lipid alignment have been
primarily anecdotal, and the diversity in lipid composition,
peptide concentration, and experimental conditions used to
date prohibit a systematic evaluation of how peptide
sequences and lengths affect macroscopic lipid organization.
Finally, for our systems, although the POPG CSA values
decrease on addition of KL4, the lipids clearly remain in
a lamellar phase above the phase transition temperature.
TABLE 1 31P CSA values (in ppm) for 3:1 POPC/POPG and 4:1
DPPC/POPG with varying concentrations of KL4 (peaks in the
dePaked spectra had full widths at half-height of 1–5 ppm)
mol % KL4
4:1 DPPC/POPG 3:1 POPC/POPG
DPPC POPG POPC POPG
0 44.8 38.2 45.8 38.6
.06 46.0 37.6 46.0 38.5
.13 45.4 37.8 46.2 38.7
.2 44.8 37.4 44.0 38.4
.31 45.2 37.1 45.1 38.6
.63 45.8 36.2 45.3 37.3
.94 46.1 35.2 46.4 36.6
1.0 45.0 35.2 44.7 36.7
1.89 45.5 34.9 45.8 36.9
3.0 45.0 32.7 44.5 35.3
Individual lipids
DPPC POPG POPC
0 48.0 34.4 46.2
1.5 44.6 34.7 47.3Biophysical Journal 96(10) 4085–4098
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on addition of KL4
To determine whether the domain formation observed in the
DSC experiments was due to phase separation of the DPPC
and POPG lipids, 2H NMR spectra were collected over the
temperature range of the phase transitions for samples that
contained either deuterated DPPC or deuterated POPG
(Fig. 5). A first-moment analysis of these data to determine
the phase transition temperatures is provided in the Support-
ing Material. From these spectra, it is clear that in the 4:1
DPPC/POPG samples the lipids are fully miscible, with
the DPPC and POPG melting at similar temperatures. The
phase transition seen for deuterated DPPC is at a slightly
lower temperature (midpoint of 30.7C) than for deuterated
POPG (31.1C). This is partly because a larger percentage
of the fatty acyl chains is deuterated (80% vs. 10%) (57),
but it may also reflect slight differences in POPG content
between the two samples since they were made from
different lipid stock solutions. For the samples that do not
contain KL4, the spectra at intermediate melting tempera-
tures are a superposition of gel phase and liquid phase
spectra. Addition of KL4 affects the phase transition temper-
ature of both lipids in a similar manner, based on the first-
moment analysis. However, in the POPG-d31 spectra a larger
percentage of the dynamic lipid phase is evident, and in the
DPPC-d62 spectra the dynamic phase is absent at lower
temperatures, as can be seen by comparing spectra at
30C and 32C. The peptide also leads to an increase in
temperature at which the lipids are completely melted
(36C vs. 40C for deuterated DPPC; 38C vs. 40C for
deuterated POPG), consistent with the DSC data. Attempts
to determine the fractions of liquid phase and gel phase
by spectral subtractions with samples containing differing
percentages of KL4 were unsuccessful due to variations in
the lipid alignment and acyl chain order parameters. Thus,
addition of KL4 leads to some phase separation of the lipids
at lower temperatures, with a significant fraction of POPG
remaining in the gel phase. Above the phase transition
temperature of the domain with the higher Tm, the peaks
in the 2H spectra coalesce to a single resonance for each
position in the acyl chain, suggesting the absence of separateBiophysical Journal 96(10) 4085–4098domains in the fluid phase or exchange between domains is
fast on the NMR timescale.
Effects of KL4 on lipid acyl chain dynamics
Further analysis of 2H NMR spectra above the lipid phase
transition temperatures allows determination of the effect
of KL4 on lipid acyl chain dynamics in the fluid phase,
and provides insight into its partitioning depth into the bila-
yers. 2H NMR spectra for 3:1 POPC-d31/POPG and 4:1
DPPC-d62/POPG MLVs at 44
C with varying levels of
KL4 were collected and dePaked (Fig. 6). For 3:1 POPC-d31/
POPG MLVs, only small decreases are seen in the ordering
of the POPC sn-1 acyl chains on addition of KL4. In contrast,
addition of KL4 to 4:1 DPPC-d62/POPG MLVs increases
the ordering of the DPPC acyl chains, particularly toward
the middle of the bilayer. This suggests that either 1), KL4
inserts deeply into the DPPC/POPG bilayers, restricting
the motional freedom of the acyl chains; or 2), an electro-
static interaction of the peptide with the lipid headgroups
occurs, resulting in a change in the lipid packing and head-
group conformation. However, the 31P experiments des-
cribed above establish that the phosphate moieties in the
PC headgroups are unaffected by KL4, ruling out the latter
possibility.
Lipid acyl chain order parameters were determined by
measuring the quadrupolar splitting (DvQ) for deuterium
atoms at various positions along the acyl chain and deter-
mining their order parameters, SCD (Eq. 1). The order param-
eters provide a measure of the average angular fluctuations
around the bilayer normal at each acyl chain segment (58):
DyQ ¼ 3
4
e2qQ
h

3cos2q 1SCD: (1)
For saturated C-D bonds, the quadrupole coupling, 3
4
e2qQ
h ,
is 167 kHz in the static limit (59). If the bilayers adopt
random orientations with respect to the magnetic field, the re-
sulting spectra of perdeuterated acyl chains are comprised of
a superposition of axially symmetric powder patterns arising
from each deuterated position. The intensities of these
powder patterns follow the well-established distribution
function p(q) f sin(q), where q is the angle between theFIGURE 5 Deuterium NMR spectra
as a function of temperature for (a) 4:1
DPPC-d62/POPG MLVs, (b) 4:1
DPPC-d62/POPG MLVs with KL4 at a
P/L molar ratio of 1:53, (c) 4:1 DPPC/
POPG-d31 MLVs, and (d) 4:1 DPPC/
POPG-d31 MLVs with KL4 at a P/L
molar ratio of 1:33.
KL4 Lipid Interactions 4091bilayer normal and the magnetic field. The overlaid powder
patterns can be deconvoluted using a standard inversion
(dePaking) procedure (60). For a sample in which the lipid
bilayers show a tendency to align in the magnetic field, the
probability distribution function must be adjusted. Assuming
that the magnetic field leads to an ellipsoidal deformation of
the MLVs, the probability distribution becomes (40):
pðEÞðqÞfsinðqÞ½1 ð1 kEÞcos2q2: (2)
Here kE refers to the square of the ratio of the long to short
axes of the ellipsoids. Using an iterative procedure, which
simultaneously determines kE and dePakes the spectrum,
the order parameters, SCD, can be determined with high accu-
racy in a partially aligned sample along with the degree of
alignment. Order parameters calculated using deconvoluted
spectra (Fig. 6) are tabulated in the Supporting Material;
the resulting order parameter profiles are graphed in Fig. 7.
The order parameter profiles clearly indicate that KL4 has
different effects on POPC versus DPPC lipids, with a small
decrease in order for the POPC lipids and a larger increase in
order for the DPPC lipids. The profiles also yield a more
detailed picture of how KL4 affects the lipid dynamics,
with carbon positions 2–8 being the most affected in the
POPC lipid acyl chains and positions 9–16 the most affected
FIGURE 6 DePaked deuterium NMR spectra of (top) 4:1 DPPC-d62/
POPG and (bottom) 3:1 POPC-d31/POPG MLVs with KL4 at the indicated
P/L ratios. Spectra were taken at 44C.in the DPPC lipid acyl chains. The effects of KL4 on the PG
lipids were similarly monitored by collecting 2H NMR
spectra for 4:1 DPPC/POPG-d31 and 3:1 POPC/POPG-d31
MLVs and calculating the order parameter profiles for the
sn-1 chain on POPG in these lipid mixtures (Supporting
Material). In these experiments an overall decrease in
ordering of the POPG acyl chains, particularly in the plateau
region, is seen on addition of KL4. Decreases in the order
parameters are seen at all the acyl positions in POPG in
3:1 POPC/POPG MLVs and are greater than the changes
for POPC in the plateau region. The POPG acyl chain order
parameters in 4:1 DPPC/POPGMLVs do not appear to be as
affected by KL4; however, a comparison of the results further
down the acyl chain for POPG-d31 when mixed with DPPC
versus POPC again demonstrates that the peptide interacts
with these lipid systems in a manner that depends on the
degree of saturation of the fatty acid chains.
To clarify the effects of KL4 on the individual lipids in the
binary lipid mixtures, 2H NMR spectra of neat lipids, DPPC-
d62, POPC-d31, and POPG-d31, with and without 1.5 mol %
KL4 were also collected, dePaked, and assigned (Supporting
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FIGURE 7 Order parameter profiles for the sn-1 chain of (top) DPPC-d62
in 4:1 DPPC-d62/POPG and (bottom) POPC-d31 in 3:1 POPC-d31/POPG
MLVs with KL4 at the indicated P/L ratios.Biophysical Journal 96(10) 4085–4098
4092 Antharam et al.Material). A comparison of these order parameter profiles
with those for the lipids in binary mixtures shows that the
DPPC order parameters for 4:1 DPPC/POPG MLVs with
P/L ratios > 1:200 are higher than would be expected for
DPPC alone, and the POPG order parameters are also higher
than expected for POPG alone. Within the resolution of the
2H NMR experiment, no phase separation is seen. Thus, KL4
is most likely interacting with both lipid populations in the
fluid phase rather than segregating the lipids and interacting
with a single phase above the Lb-to-La phase transition.
The observed changes in order parameters are seen more
clearly when the data are viewed as the change in order
parameter at each position along the acyl chain on addition
of peptide relative to the order parameters of the lipids
without the peptide. Shown in Fig. 8 are the changes in order
parameters at particular methylene positions in the sn-1
palmitoyl acyl chains for the individual lipids in 3:1
POPC/POPG and 4:1 DPPC/POPG MLVs, respectively,
on addition of peptide at a P/L molar ratio on the order of
1:100. From these graphs, the behavior of the PG lipids rela-
tive to the PC lipids is clearly offset, but the trends with
respect to acyl chain position are similar. The offset of the
profiles for the PG lipids is consistent with the 31P NMR
findings described above, showing that association of KL4
with the lipids leads to a change in the orientation PG head-
groups and an overall decrease in the 31P CSAs for the POPG
lipids. Thus, the offset in the PG profiles in Fig. 8 relative to
the PC profiles does not reflect significantly less internal
order in the PG lipid methylene chains per se, but instead
reflects a change in the average orientation of the PG lipid
director relative to the membrane normal.
The larger decrease in order parameters for POPG versus
POPC in 3:1 POPC/POPG MLVs reflect the reorientation of
the PG headgroup, and the lipid acyl chains are most likely
equally affected in terms of the internal dynamics of the
methylene chains. From their profiles, one can see that for
this lipid system the methylenes in the plateau region are
more affected than those further down the acyl chain. This
behavior is somewhat in contrast to changes observed for
antimicrobial peptides, which typically cause larger changes
in order further down the methylene chain (37,61,62), and
suggests that the interaction of KL4 with monounsaturated
lipids is unlike antimicrobial amphipathic helices, which
have a much higher percentage of charged residues and are
known to disrupt membrane bilayers. Changing the order
of amino acids in the primary sequence of KL4 to mimic
a standard amphipathic a-helix abolishes its effectiveness
as a surfactant (63). However, its behavior is similar to that
of the C-terminus of SP-B, SP-B59–80 (64), and saposin C,
a protein that is important for lipid enzymology and is
closely related to SP-B (65,66).
Of particular interest regarding the role of KL4 in lung
surfactant formulations is its effects on 4:1 DPPC/POPG
MLVs. From the order parameter profiles, one can see that
KL4 clearly increases in order along the DPPC acyl chains,Biophysical Journal 96(10) 4085–4098with the greatest effect at the center of the bilayers. The
profile for POPG also shows an increase toward the center
of the bilayers but a decrease in the plateau region. However,
as discussed above, the decrease reflects a change in the
average orientation of the POPG headgroup, and if this
change in orientation is taken into account, the internal order
at individual methylene positions in the POPG acyl chain is
increasing over the entire length of the acyl chain. We previ-
ously observed these same trends for SP-B59–80 (64). Similar
behavior has also been observed on addition of the human
antimicrobial peptide LL-37 to DMPC bilayers (61).
Increases in lipid acyl chain ordering have been observed
in response to polyelectrolyte binding to lipid headgroups
(67,68), as well as in response to the addition of small mole-
cules, such as cholesterol (69,70), or TM peptide helices that
partition into the acyl chain region of the lipids (71,72). In
the case of polyelectrolyte binding, larger changes are seen
for the plateau region of the lipids, reflecting a change in
overall orientation of the lipid packing and headgroups.
a
b
FIGURE 8 Changes in sn-1 d31-palmitoyl acid chain order parameters for
PC lipids (squares), and POPG (triangles) in 4:1 DPPC/POPG MLVs (top)
and 3:1 POPC/POPG (bottom).
KL4 Lipid Interactions 4093Smaller changes are also seen near the center of the bilayers
and are interpreted as resulting from closer packing of the
lipids on binding of the electrolyte. It is unlikely that KL4
is affecting the lipid bilayers in this manner, since the 31P
results above show little change in the dynamics of the PC
headgroups. For TM helices similar in length to KL4,
increases in order parameters that are similar in magnitude
are seen for both the methylene positions in the plateau
region and toward the center of the bilayers; these trends
are observed in both POPC and DPPC bilayers. This is ex-
pected because insertion of a TM helical peptide primarily
affects the thickness of the bilayer, and it would interact
with both the lipid acyl chains and headgroups across the
entire span of the bilayers. In contrast, for cholesterol, larger
changes in order parameters are observed toward the center
of the bilayer (69) because cholesterol partitions to the
bilayer interior and does not strongly interact with the lipid
head groups. The effects of KL4 and SP-B59–80 on the order
parameters in DPPC/POPG bilayers are most similar to those
of cholesterol. This suggests that the bulk of the peptides are
partitioning deep within the lipid bilayers. The higher degree
of ordering toward the center of the bilayer could be due to
the leucines in KL4 penetrating deeply into the bilayer and
decreasing the mobility of the acyl chains. However, the
smaller changes seen in the plateau region (carbons 3–8)
suggest that the peptide does not adopt a TM orientation.
These changes in order parameters indicate that KL4 lodges
into the hydrophobic region of the bilayer while maintaining
its helix axis perpendicular to the bilayer normal. This type
of interaction would lead to a negative curvature strain
within the lipid bilayers, a phenomenon that has been
hypothesized to be important for lung surfactant function
(4). Of interest, 2H spectra of 3:1 POPC/POPG lipid mixtures
collected at 10C (data not shown) show that KL4 increases
acyl chain order in a manner similar to that seen for 4:1
DPPC/POPG mixtures at 44C. Thus, the contrast in the
effects of KL4 on lipid dynamics in the two lipid systems
at physiologic temperatures is related to the difference
between the temperature of observation and the phase transi-
tion temperatures of the individual lipid systems.
Another interesting outcome is seen when one compares
the effect of KL4 on DPPC and POPC acyl chains in mixed
DPPC/POPG and POPC/POPG bilayers relative to the PC
lipids alone (Fig. 9). Given the highly conserved lipid
composition found in mammalian lung surfactants, POPG
is most likely a critically important factor in the physical
properties of surfactant. For both lipid systems, the incorpo-
ration of POPG leads to a greater change in the order param-
eter profiles of the PC lipids on addition of KL4. Although
the anionic POPG interacts with the peptide through electro-
static interactions with the lysine side chains, this interaction
seems to increase the miscibility of the peptide with the PC
lipids in the fluid phase rather than leading to phase separa-
tion, as evidenced by its increased effects on the PC lipid
order parameters with addition of POPG.Binding and insertion depth of KL4 into lipid
bilayers
To more directly gauge the insertion depth of KL4 into the
DPPC/POPG and POPC/POPG bilayers, samples were
prepared for 1H spin diffusion experiments. For these exper-
iments, the peptide was 13C0 enriched at positions L9 and
L10, and initial CPMAS spectra were collected to assess
the dynamics and cross-polarization efficiency of the peptide
(Fig. 10 a). The sample containing DPPC affords high-
quality CPMAS spectra with an easily discernible 13C0 reso-
nance at 172 ppm. However, 13C’ resonances are not as
clearly seen in the CPMAS spectra for the sample containing
POPC at 25C and 40C, and cross polarization is less effi-
cient. Cooling the samples down to nearer the phase transi-
tion temperature of the lipids leads to the appearance of
peptide 13C0 signal at 174 ppm. Thus the peptide is clearly
bound and immobilized in the fluid-phase DPPC/POPG bila-
yers on the NMR timescale, but when interacting with the
POPC/POPG bilayers at physiologic temperatures it is only
transiently bound or highly mobile. This contrasts with
previous observations of the binding of KL4 to POPC/
POPG LUVs in 5 mM HEPES buffer alone (73). Similar
variations in peptide dynamics for a peptide ion channel
mixed with lipids in organic solvents or bound to lipid
LUVs from buffer have been observed (74). Of interest,
these differences in dynamics do not necessarily correlate
to global changes in secondary structure, as the isotropic
chemical shifts for enriched 13C0 positions in KL4 in the
two POPC/POPG sample preparations are indistinguishable
when the samples are flash-frozen (at ~172 ppm) and the
two preparations yield similar CD spectra. However, we do
see a slight change in the isotropic chemical shifts between
the two POPC/POPG preparations when the lipids are in
the fluid phase: the more dynamic preparation, resulting
FIGURE 9 Changes in sn-1 d31-palmitoyl acid chain order parameters for
DPPC (squares) and POPC (circles) MLVs with (closed symbols) and
without (open symbols) POPG on addition of KL4 at P/L molar ratios of
~1:100.Biophysical Journal 96(10) 4085–4098
4094 Antharam et al.FIGURE 10 (Left) CPMAS spectra of KL4 in 4:1 DPPC:
POPG vesicles (top), collected at 40C, and 3:1 POPC:
POPG vesicles (bottom), collected near 0C, at a P/L molar
ratio of 1:33. The peptide is 13C0-enriched at positions L9
and L10. Peptide resonances (*) and lipid resonances (þ)
are indicated. In the expansion of the region for the 13C0
isotropic and first spinning sideband resonances, the atten-
uation of peptide signal in 3:1 POPC/POPG vesicles can be
seen and the lipid signals are more prevalent. (Right) 2D
13C-detected 1H spin-diffusion spectrum for 1:33 KL4 in
4:1 DPPC/POPG with the peptide (*) and lipid (þ) 13C
resonances indicated in the t1 ¼ 0 experiment (top).from mixing KL4 with lipids in an organic phase, has an
isotropic chemical shift near 174 ppm (Fig. 10 a), whereas
the less dynamic preparation has an isotropic chemical shift
of 172 ppm (73). Carbonyl 13C0 signals are particularly
susceptible to slight variations in hydration and/or hydrogen
bonding (75), which would explain these observations. The
transient nature of the KL4 interactions with the POPC/
POPG bilayers would also explain why its effects on acyl
chain order are attenuated relative to its effects on order in
DPPC/POPG bilayers.
The interaction of KL4 with the DPPC/POPG bilayers in
the fluid phase was characterized by means of 1H spin diffu-
sion experiments. Fig. 10 b shows a representative 13C-de-
tected 1H spin diffusion spectrum at a mixing time of
100 ms, in which an interaction of the peptide 13C0 reso-
nances at ~172 ppm with the lipid acyl chains at a 1H chem-
ical shift of 1.3 ppm is clearly seen. Although the lipids are
also exchanging polarization with water, as evidenced by
a cross-peak at a 1H chemical shift of 4.7 ppm and a 13C
chemical shift of 30 ppm, no appreciable signal correspond-
ing to spin diffusion between the peptide and water is seen.
This observation is consistent with the peptide penetrating
deeply into the lipid bilayers (43).
DISCUSSION
The dynamic air-fluid interface in the lung requires lung
surfactant to possess specific attributes to lower surface
tension and allow rapid respreading of lipids. Lung surfac-
tant relies on relatively low levels of lung surfactant proteins
B and C (<0.2 mol %) to alter the structure, dynamics, and
phase properties of the lipids. The peptide KL4 similarly
affects the macroscopic properties of the lipids and has
been pursued as a clinical replacement for SP-B in thera-
peutic formulations (30,33). However, the molecular mech-
anisms behind its properties have not been fully elucidated.
FTIR measurements of SP-B interacting with lipid bilayers
indicate that it is a helical protein with the helices oriented
perpendicular to the membrane normal (19,20). FTIR studies
of KL4 in which the amide I
0 band was monitored led to con-Biophysical Journal 96(10) 4085–4098flicting models of the structure and orientation of the peptide.
In early work using oriented bilayers at limited hydration,
investigators concluded that KL4 was helical in 7:3 DPPC/
DPPG but spanned the bilayers (76). Later work with
DPPC and DPPG mixed monolayers at an air-water interface
indicated that KL4 lies along the surface of the lipids as
a mixture of helix and sheet (77). However, in both of these
studies it was assumed that KL4 forms either a classic
a-helical or b-sheet secondary structure with standard back-
bone conformations and hydrogen-bonding distances. Addi-
tionally, the amide I0 band is sensitive to the solvation envi-
ronment of the peptide being monitored, and thus variable
partitioning into the lipid environments could explain the
observed changes in stretching frequencies. More recently,
an in vitro transcription-translation system, which utilizes
the Escherichia coli inner membrane protein leader pepti-
dase (Lep) to report on the integration of TM helices into
ER membranes, was used to assay whether KL4 or SP-
B59–80 would partition as TM helices in the context of
a Lep model protein (78). In that study, KL4 was found to
incorporate into the protein as a TM helix whereas SP-B59–
80 did not. However, the accuracy of this host-guest system
for predicting the partitioning of positively charged amphi-
pathic sequences has been called into question given the
complexity of the translocon protein assembly and mecha-
nisms of glycosylation (79–81). The possible secondary
structures of KL4, as well as its interactions with specific
lipids found in lung surfactant, need more thorough exami-
nation. In an attempt to gain a molecular-level understanding
of how KL4 alters lipid properties, we undertook an ssNMR
examination of how KL4 interacts with two lipid formula-
tions: 4:1 DPPC/POPG and 3:1 POPC/POPG.
Our CD measurements, as well as previously published
work (46), show KL4 to be helical in both POPC/POPG and
DPPC/POPG lipid mixtures. However, in all probability,
KL4 does not form a classic a-helix if the helix axis is perpen-
dicular to the membrane normal, since this would place the
lysines evenly around the helix (Fig. 2 A). Lysine- and
leucine-rich peptides have been shown to adopt different
amphipathic secondary structures at the air-water interface
KL4 Lipid Interactions 4095and on polymer surfaces based on the amino acid pattern of the
residues (82,83). Similar driving forces would exist at the lipid
bilayer surface. A possible explanation for howKL4 partitions
as a helix into the bilayers is that it may form a structure in
which the lysines lie on one side of a helix. The length andflex-
ibility of the lysine side chains would allow either an amphi-
pathic helical conformation of KL4, which preferentially binds
at the lipid interface (Fig. 2 B), or a p-helix conformation in
which the peptide deeply penetrates into the bilayer
while retaining electrostatic interactions between the lysine
side chains and the lipid phosphate groups by ‘‘snorkeling’’
(Fig. 2 C). We recently determined the structure of KL4 in
3:1 POPC/POPGMLVs via ssNMRdipolar recoupling exper-
iments (73). The average backbone torsion angles found were
(105, 30), which allow KL4 to form an amphipathic helix
in which the lysines lie on one half of the peptide helix as in
Fig. 2B. This would allow the peptide to preferentially interact
with the lipids at the bilayer interface, but would make deeper
penetration into the hydrophobic region of the lipids unfavor-
able. Measurements of the structure of KL4 in DPPC/POPG
MLVs suggest i to i þ 5 hydrogen bonding (A. K. Mehta
and J. R. Long, unpublished data). Of interest, the CD spec-
trum for KL4 interacting with DPPC/POPG LUVs is very
similar to that observed for recently published peptides that
are constrained by covalent bonds to form p-helices (44).
Another consideration is whether the helical form of KL4
might span the bilayers in a TM conformation. The snor-
keling of lysine residues was previously postulated to stabi-
lize the TM WALP and KALP peptides (84). However, the
length of the lysine side chain limits its placement relative
to the peptide termini for a TM orientation to be observed.
Of specific interest regarding the orientation of KL4 are the
22 amino acid peptides KKLLKLLLLLLLLLLKLLLLKK
and KKLLLLLKLLLLLLLKLLLLKK, which have been
characterized in POPC membranes. The former peptide
adopts a TM orientation, whereas the latter peptide
exchanges slowly between different orientations in the bila-
yers (85). These peptides bear a striking homology to KL4 in
both amino acid content and hydrophobic to hydrophilic
ratio, but only the sequence in which the lysines are distrib-
uted more toward the termini is able to achieve a stable TM
configuration. The thermodynamic penalty imposed by
placing KL4 in a TM orientation would be prohibitive since
it would result in charged amino acids partitioned into the
hydrophobic core. Thus KL4 most likely binds lipid
membranes in an amphipathic helical conformation with
the helix axis parallel to the plane of the bilayers. This orien-
tation is supported by comparison of the effects of KL4 and
SP-B59–80 on lipid dynamics (86). Both peptides yield strik-
ingly similar results when the changes in the dynamics of
fully hydrated POPC/POPG and DPPC/POPG mixtures are
examined, and their effects are somewhat similar to those
of the antimicrobial peptide LL-37 at low peptide/lipid ratios
(61). It has been established that both LL-37 and SP-B59–80
form helical structures at lipid interfaces rather than spanninglipid bilayers. In all likelihood, the studies that found KL4 to
adopt a TM orientation suffered from the conditions of the
experiments; however, it is likely that deep partitioning of
the peptide into the membrane is energetically more favor-
able, and this may be a key feature in its function within
lung surfactant.
The variation in the amphipathic helical structure of KL4
sets it apart from classic amphipathic a-helices. Cationic,
leucine-rich amphipathic helical peptides have been pursued
as antimicrobial agents because their positive charge leads to
preferential targeting of the anionic-rich membranes typical
of prokaryotes (87). These peptides are specifically intended
to form amphipathic a-helices based on naturally occurring
antimicrobial peptides, and disrupt membranes on binding
through the carpet mechanism or the formation of toroidal
or barrel stave pores (87–89). However, these peptides
have a significantly higher percentage of charged residues
(>50% vs.<25% for KL4), and the periodicity of the hydro-
phobic and hydrophilic residues is designed to favor classic
amphipathic a-helices. We find no indication of membrane
disruption by KL4, consistent with the notion that its mech-
anism of interaction with lipids differs from that of antimi-
crobial peptides. The higher hydrophobicity of the amphi-
pathic KL4 helices modeled in Fig. 2 would favor more
interaction with the lipid acyl chains relative to the lipid
headgroups and thus would exert less positive curvature
strain on the lipid bilayers.
Our data on lipid dynamics support our conclusions
regarding the helical structure and orientation of KL4. In
POPC/POPG bilayers, a decrease in acyl chain order on addi-
tion of peptide suggests partitioning of the peptide into the
lipid headgroup region. The acyl chain ordering in the
DPPC/POPG lipids is more marked at positions 9–15 than
in the plateau region, suggesting deep penetration of the
peptide into the lipid bilayer with less perturbation of the
headgroup region than is seen for leucine-rich TM helices.
A p-helical conformation with snorkeling of the lysines
would allowKL4 to penetrate more deeply into saturated lipid
bilayers while remaining perpendicular to the bilayer normal.
The proposed snorkeling of KL4 within DPPC/POPG lipid
multilamellar vesicles would have important consequences
for membrane structure and function. This represents a novel
peptide-lipid interaction that is unusual in comparison to what
has been seen for membrane active amphipathic a-helices.
Although the binding of KL4 to POPC/POPG vesicles
suggests that it could bind to these lipids in a manner similar
to amphipathic a-helices, its ability to snorkel in DPPC/
POPG lipids would have a different effect on lipid biophysics,
particularly in the alveoli. Some of the thermodynamic costs
of peptide penetration can be relieved by the formation of
alternative nonlamellar structures, such as hexagonal phases
(90,91). The formation of alternative lipid geometries, specif-
ically the inverted HII phase, has been found to be important
for lung surfactant function (4). It has also been hypothesized
that SP-B causes negative curvature strain in lung surfactantBiophysical Journal 96(10) 4085–4098
4096 Antharam et al.and may even favor the formation of a hexagonal phase.
Although we did not observe a hexagonal phase in this study,
the partitioning of KL4 deep into the DPPC/POPG bilayers
would significantly increase negative curvature strain. The
addition of small levels of cholesterol or POPE could further
affect the curvature strain in the lipid bilayers and cause the
formation of a hexagonal phase. Studies of the effect of KL4
on other model lung surfactant compositions are ongoing.
Preliminary work with DPPE/POPG lipids indicates that
KL4 promotes the formation of the HII phase at lower temper-
atures. Alternatively, lipid geometry could be critical during
fusion of lipids to the air-surfactant interface, and KL4 snor-
keling could be an essential feature for the proper shuttling
of lipids. Our studies also highlight that the properties of
KL4 are lipid-dependent, and thus KL4 could play a role in
differential lipid partitioning to the air-water interface.
CONCLUSIONS
The unique interplay among lipid saturation, peptide pene-
tration, and peptide structure we observed could explain
the unique properties of KL4 in the dynamic lung environ-
ment. DSC, 31P, 2H, 13C CPMAS, and 1H spin diffusion
data all indicate that KL4 binds peripherally to 3:1 POPC/
POPG lipids through electrostatic interaction of the lipid
phosphates with the positively charged lysines. A different
interaction is seen with 4:1 DPPC/POPG lipids, suggesting
that the peptide penetrates to a far greater depth in the
bilayer. CD measurements indicate that the peptide is helical
in both lipid environments, although the amount and char-
acter of the helix are lipid-dependent; alterations in helix
pitch would allow KL4 to adapt its structure to match the
environment for different insertion depths. Thus, both
peptide structural plasticity and acyl chain saturation play
an important role in determining the insertion level of KL4.
The variations in peptide penetration would directly affect
the stability and composition of lipid structures in lung
surfactant by increasing positive curvature strain in POPC-
enriched domains and increasing negative curvature strain
in DPPC-enriched domains. These changes in curvature
strain would provide a mechanism for lipid trafficking
from lamellar bodies and tubular myelin to the air-water
interface in a manner selective for DPPC. The enrichment
of DPPC at the air-water interface has been postulated to
be one of the major roles of SP-B. The plasticity of KL4 in
its structure and insertion depth could be a consequence of
the spacing of hydrophilic amino acids every five residues;
the paucity of aromatic residues, which favor partitioning
to the lipid interface; the high percentage of leucine residues,
which favors interactions with lipid acyl chains; the choice of
lysines for the charged amino acids, which allows for side-
chain snorkeling; or a combination of these factors. The
importance of each of these characteristics to the partition-
ing, insertion, and structure of amphipathic helices relevant
to lung surfactant is the subject of ongoing studies. WithBiophysical Journal 96(10) 4085–4098the findings presented here, a more thorough molecular
model can be established to explain how this small peptide
modulates lipid properties and drive the development of
future SP-B mimetics.
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